- ►annals.org [PDF] WT Cefalu, JS Skyler, IA Kourides, WH … - Annals of internal medicine, 2001 - Am Coll Physicians Inhaled Human Insulin Treatment in Patients with Type 2 ... William T. Cefalu,
MD; Jay S. Skyler, MD; Ione A. Kourides, MD; William H. Landschulz, MD, PhD;
Cecile C. Balagtas, PhD; Shu-Lin Cheng, PhD; and Robert A. Gelfand, MD, for ... Cited by 170 - Related articles - BL Direct - All 7 versions
JS Skyler, WT Cefalu, IA Kourides, WH … - The Lancet, 2001 - Elsevier 73 patients with type 1 diabetes mellitus were studied in an open-label,
proof-of-concept, parallel-group randomised trial. Patients in the experimental
group received preprandial inhaled insulin plus a bedtime subcutaneous ... Cited by 259 - Related articles - BL Direct - All 8 versions
L Heinemann, T Traut, T Heise - Diabetic Medicine, 1997 - profil-research.de Dm _Ч J ORINAL ARTICLES Time-action Profile of Inhaled Insulin L. Heinemann, T.
Traut, T. Heise Department of Metabolic Diseases and Nutrition, WHO
Collaborating Centre for Diabetes, Heinrich-Heine-University Düsseldorf, ... Cited by 107 - Related articles - BL Direct - All 5 versions
- Free from Publisher RA Gerber, JC Cappelleri, IA Kourides, RA … - Diabetes Care, 2001 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Subjects with type 1 diabetes participated in a
12-week open-label trial and were randomized to either an inhaled insulin
regimen or a subcutaneous insulin regimen. Subjects (n = 69) were asked to ... Cited by 101 - Related articles - BL Direct - All 8 versions
GA Brunner, B Balent, M Ellmerer, L Schaupp, … - Diabetologia, 2001 - Springer In order to optimise insulin treatment, insulin ana- logues for subcutaeous
injection have been designed recently [1]. Substantial efforts have also been
direct- ed towards finding alternative routes for insulin ad- ministration ... Cited by 89 - Related articles - BL Direct - All 4 versions
JC Cappelleri, WT Cefalu, J Rosenstock, IA … - Clinical therapeutics, 2002 - Elsevier Methods: This was a 12-week randomized, open-label, parallel-group, controlled
trial in patients with type 2 diabetes. They were randomized to receive either a
subcutaneous insulin regimen (split/mixed insulin with 2 to 3 injections ... Cited by 78 - Related articles - All 5 versions
- ►colfar.com [PDF] - Free from Publisher PA Hollander, L Blonde, R Rowe, AE Mehta, … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS— HbA 1c decreased similarly in the inhaled (−0.7%) and subcutaneous
(−0.6%) insulin groups (adjusted treatment group difference: −0.07%, 95% CI
−0.32 to 0.17). HbA 1c <7.0% was achieved in more patients receiving ... Cited by 237 - Related articles - BL Direct - All 21 versions
- ►diabetesjournals.org K Rave, S Bott, L Heinemann, S Sha, RHA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—INH had a faster onset of action than both RHI and ILP, as indicated
by shorter time to early half-maximal effect (32 vs. 48 and 41 min,
respectively; P < 0.001 for IHN vs. RHI and P < 0.05 for IHN vs. ILP). Time ... Cited by 112 - Related articles - All 7 versions
- ►diabetesjournals.org J Rosenstock, JC Cappelleri, B Bolinder, RA … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Of the 60 patients who received inhaled insulin during the parent
studies, 85.0% (n = 51) chose to continue treatment, 13.3% (n = 8) switched to
subcutaneous insulin, and 1.7% (n = 1) did not continue. Of the 61 patients ... Cited by 132 - Related articles - BL Direct - All 12 versions
- ►annals.org [PDF] J Rosenstock, B Zinman, LJ Murphy, SC … - Annals of internal medicine, 2005 - Am Coll Physicians Inhaled Insulin Improves Glycemic Control When Substituted for or ... Added to
Oral Combination Therapy in Type 2 Diabetes ... Julio Rosenstock, MD; Bernard
Zinman, MD; Liam J. Murphy, MD; Stephen C. Clement, MD; Paul Moore, MD; C. ... Cited by 163 - Related articles - BL Direct - All 8 versions
